Cita APA

Sayar, Z., Czuprynska, J., Patel, J. P., Benjamin, R., Roberts, L. N., Patel, R. K., . . . Arya, R. (2019). What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial. J Thromb Thrombolysis.

Chicago Style Citation

Sayar, Zara, Julia Czuprynska, Jignesh P. Patel, Reuben Benjamin, Lara N. Roberts, Raj K. Patel, Victoria Cornelius, i Roopen Arya. "What Are the Difficulties in Conducting Randomised Controlled Trials of Thromboprophylaxis in Myeloma Patients and How Can We Address These? Lessons From Apixaban Versus LMWH or Aspirin As Thromboprophylaxis in Newly Diagnosed Multiple Myeloma (TiMM) Feasibility Clinical Trial." J Thromb Thrombolysis 2019.

Cita MLA

Sayar, Zara, et al. "What Are the Difficulties in Conducting Randomised Controlled Trials of Thromboprophylaxis in Myeloma Patients and How Can We Address These? Lessons From Apixaban Versus LMWH or Aspirin As Thromboprophylaxis in Newly Diagnosed Multiple Myeloma (TiMM) Feasibility Clinical Trial." J Thromb Thrombolysis 2019.